Harcharan Gill
Academic Appointments
- Associate Professor - Med Center Line, Urology
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Uro-Oncology Clinic 875 Blake Wilbur Dr Clinic E Stanford, CA 94305 Tel Work (650) 725-5544 Fax (650) 723-0765
- Academic Offices
Personal Information Email Tel (650) 725-5544Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Urologic Oncology
- Bladder Cancer - Urologic Oncology
- Bladder Cancer
- Kidney Cancer
- Penile Cancer
- Prostate Cancer
Administrative Appointments
- Clerkship Director, Urology (1998 - 2005)
- Program Director, Residency program (2006 - present)
Professional Education
| Board Certification: | Urology, American Board of Urology (1995) |
| Fellowship: | University of Pennsylvania School of Medicine PA (1991) |
| Residency: | Institute Of Urology, England (1987) |
| Residency: | Royal College of Ireland, Ireland (1982) |
| Internship: | Kenyatta National Hosp. (1978) |
| Medical Education: | University Of Nairobi, Africa (1977) |
Internet Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
Benign Prostatic Hyperplasia- Evaluation of new minimally invasive techniques. HIFU and cryotherapy are being evaluated as a image guided minimally invasive technique for the treatment of symptomatic BPH
Clinical Trials
- Recruiting Quality of Life Following Radical Prostatectomy
- Recruiting Prostate Active Surveillance Study
- Not Recruiting "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
- Not Recruiting Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)
- Not Recruiting Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study
Publications
- Surgical outcomes and complications associated with presurgical tyrosine kinase inhibition for advanced renal cell carcinoma (RCC). Urol Oncol. 2013; (3): 379-85
- MR imaging-guided cryoablation for the treatment of benign prostatic hyperplasia. J Vasc Interv Radiol. 2011; (10): 1427-30
- Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int. 2011; (1): 82-8
- Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A. 2009; (33): 14016-21
- Laparoscopic management of ureteral endometriosis: the Stanford University hospital experience with 96 consecutive cases. J Urol. 2009; (6): 2748-52
- MR imaging-guided percutaneous cryoablation of the prostate in an animal model: in vivo imaging of cryoablation-induced tissue necrosis with immediate histopathologic correlation. J Vasc Interv Radiol. 2009; (2): 252-8
Help